Lanzamiento Enero 2027

Ensayo controlado aleatorizado2011Financiación no declarada

Caffeine protects against increased risk-taking propensity during severe sleep deprivation

Killgore WD, Kamimori GH, Balkin TJ

Journal of sleep research · 50 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2010-10-14 · J Sleep Res · vol. 20 · número 3 · págs. 395–403
Editorial
Wiley
Citado
90 citas · más que el 95% de estudios similares · 6.0× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
31 trabajos
Acceso
De pago
Áreas de investigación
Sleep and Work-Related Fatigue · Coffee research and impacts · Sleep and Wakefulness Research
Palabras clave
caffeine, sleep deprivation, risk-taking, Balloon Analogue Risk Task, impulsivity, cost-benefit decision making, prolonged wakefulness
MeSH
brain, humans, sleep deprivation, caffeine, central nervous system stimulants, risk-taking, neuropsychological tests, adult, female, male, young adult

3 autores

  • William D. S. Killgore🇺🇸 · autor de correspondenciaWalter Reed Army Institute of Research
  • Gary H. Kamimori🇺🇸Walter Reed Army Institute of Research
  • Thomas J. Balkin🇺🇸Walter Reed Army Institute of Research

Resumen

El texto original del estudio, en el idioma en que se publicó.

Previous research suggests that sleep deprivation is associated with declines in metabolic activity within brain regions important for judgement and impulse control, yet previous studies have reported inconsistent findings regarding the effects of sleep loss and caffeine on risk-taking. In this study, 25 healthy adults (21 men, four women) completed the Balloon Analog Risk Task (BART) and Evaluation of Risks (EVAR) scale at regular intervals to examine behavioral and self-reported risk-taking propensity during 75 h of continuous sleep deprivation. Participants received either four double-blind administrations of 200 mg caffeine (n=12) or indistinguishable placebo (n=13) gum bi-hourly during each of the 3 nights of sleep deprivation. No significant effects of drug group or sleep deprivation were evident on the BART or EVAR when measured at 51 h of wakefulness. However, by 75 h, the placebo group showed a significant increase in risk-taking behavior on the cost-benefit ratio and total number of exploded balloons on the BART, whereas the caffeine group remained at baseline levels. On the EVAR, several factors of self-reported risk-taking propensity, including total risk, impulsivity and risk/thrill seeking, were reduced among subjects receiving caffeine across the 3 days of sleep deprivation, but remained at baseline levels for the placebo group. These results suggest that 3 nights of total sleep deprivation led to a significant increase in behavioral risk-taking but not self-reported perception of risk-propensity. Overnight caffeine prevented this increase in risky behavior.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.